Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Cancer-associated Thrombosis”

60 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 60 results

Testing effectiveness (Phase 2)Ended earlyNCT01817257
What this trial is testing

Anticoagulation Length in Cancer Associated Thrombosis

Who this might be right for
CancerThrombosisVenous Thromboembolism+2 more
Cardiff University 2
Post-approval studies (Phase 4)Study completedNCT01989845
What this trial is testing

Rivaroxaban for the Prevention of Venous Thromboembolism in Asian Patients With Cancer

Who this might be right for
RivaroxabanCancer-associated ThrombosisRecurrence+1 more
Seoul National University Hospital 127
Testing effectiveness (Phase 2)Ended earlyNCT04465760
What this trial is testing

Xisomab 3G3 for the Prevention of Catheter-Associated Thrombosis in Patients With Cancer Receiving Chemotherapy

Who this might be right for
LymphomaMalignant Solid NeoplasmPlasma Cell Myeloma
OHSU Knight Cancer Institute 9
Not applicableLooking for participantsNCT06894576
What this trial is testing

Development of a Risk Stratification Score for Recurrent Venous Thromboembolism and Treatment-related Clinically Relevant Bleeding in Patients With Cancer-associated Thrombosis

Who this might be right for
Cancer-associated Thrombosis
Ottawa Hospital Research Institute 1,000
Early research (Phase 1)UnknownNCT06065592
What this trial is testing

Exploring Cancer-Associated Thromboembolism Prognosis Biomarkers and Polymorphisms

Who this might be right for
CancerSolid TumorThromboembolism+10 more
Lebanese University 500
Not applicableStudy completedNCT05461807
What this trial is testing

An Observational Study Called H2H-OSCAR-US to Learn More About How Well Rivaroxaban Works and How Safe it is Compared to Apixaban Under Real World Conditions in People in the US With Cancer Who Have Problems Due to Formation of Blood Clots in the Veins (Venous Thromboembolism)

Who this might be right for
Treatment of Venous Thromboembolism in Cancer PatientsVenous ThromboembolismCancer
Bayer 2,437
Large-scale testing (Phase 3)Study completedNCT03692065
What this trial is testing

API-CAT STUDY for APIxaban Cancer Associated Thrombosis

Who this might be right for
Cancer-associated Thrombosis
Assistance Publique - Hôpitaux de Paris 1,766
Large-scale testing (Phase 3)Study completedNCT02073682
What this trial is testing

Cancer Venous Thromboembolism (VTE)

Who this might be right for
Venous Thromboembolism (VTE)Deep Vein Thrombosis (DVT)Pulmonary Embolism (PE)+1 more
Daiichi Sankyo 1,046
Very early researchStudy completedNCT02285738
What this trial is testing

Anti-Platelet and Statin Therapy to Prevent Cancer-Associated Thrombosis

Who this might be right for
Solid TumorCancer
Case Comprehensive Cancer Center 17
Not applicableStudy completedNCT04994158
What this trial is testing

MASCOT Registry of Patients With Myeloproliferative Neoplasms Associated Splanchnic Vein Thrombosis

Who this might be right for
Myeloproliferative NeoplasmSplanchnic Vein ThrombosisJAK2 V617
Royal Free Hospital NHS Foundation Trust 238
Not applicableLooking for participantsNCT06284343
What this trial is testing

The Gynecological Cancer Associated Thrombosis (GynCAT) Study

Who this might be right for
Cancer-associated ThrombosisVenous ThromboembolismGynecologic Cancer+4 more
Fondazione Policlinico Universitario Agostino Gemelli IRCCS 1,800
Testing effectiveness (Phase 2)Looking for participantsNCT05969496
What this trial is testing

Neoadjuvant Pembrolizumab and Axitinib in Renal Cell Carcinoma With Inferior Vena Cava Tumor Thrombus

Who this might be right for
Renal CancerKidney CancerRenal Cell Carcinoma+1 more
University of Colorado, Denver 17
Large-scale testing (Phase 3)Study completedNCT02195232
What this trial is testing

Cancer Associated Thrombosis and Isoquercetin (CATIQ)

Who this might be right for
Thromboembolism of Vein VTE in Colorectal CancerThromboembolism of Vein in Pancreatic CancerThromboembolism of Vein in Non-small Cell Lung Cancer
Jeffrey Zwicker, MD 64
Not applicableLooking for participantsNCT07399977
What this trial is testing

Using a Blood Test and Software Tool to Guide Treatment for Venous Thromboembolism

Who this might be right for
Venous ThromboembolismDeep Venous Thrombosis
Memorial Sloan Kettering Cancer Center 259
Testing effectiveness (Phase 2)Ended earlyNCT03297359
What this trial is testing

WAVe Study - Weight Adjusted Dalteparin for Patients Over 90 kg With Acute Cancer Associated Venous Thromboembolism

Who this might be right for
CancerVenous ThromboembolismObesity
Ottawa Hospital Research Institute 92
Not applicableStudy completedNCT05150938
What this trial is testing

Gather Information About Rivaroxaban in Patients in Sweden With Cancer Who Also Have Thrombosis (OSCAR-SE)

Who this might be right for
Treatment of Venous Thromboembolism in Cancer Patients
Bayer 5,737
Not applicableLooking for participantsNCT07270263
What this trial is testing

Reduced-Dose Apixaban and Rivaroxaban Versus Low-Molecular-Weight Heparin in Patients With Hematologic Malignancies

Who this might be right for
LymphomaLeukemiaMultiple Myeloma (MM), Lymphoma, Large B-Cell, Diffuse (DLBCL), Lymphoma+4 more
Medical University of Gdansk 100
Not applicableStudy completedNCT03214172
What this trial is testing

Characterizing Recurrent Thromboembolism, Major Bleeding and All-Cause Death in Patients With Cancer-Associated Thromboembolism Treated With Rivaroxaban

Who this might be right for
Venous Thromboembolism
Bayer 1,000
Not applicableStudy completedNCT03114618
What this trial is testing

A New Clinic-Genetic Risk Score for Predicting Venous Thromboembolic Events in Cancer Patient

Who this might be right for
Cancer-associated ThrombosisGenetic Predisposition
Andres muñoz 416
Not applicableLooking for participantsNCT06714734
What this trial is testing

Thromboembolic and Hemorrhagic Complications of Anticoagulant Treatment in Patients With CAT

Who this might be right for
Venous Thromboembolism
IRCCS Azienda Ospedaliero-Universitaria di Bologna 1,000
Load More Results